Osaka, 541-8505,
Japan
Tanabe Pharma Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Tanabe Pharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 4490 Tanabe Pharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Tanabe Pharma has purchased the following applications: Uipath Orchestrator for Robotic Process Automation in 2018 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Tanabe Pharma is running and its propensity to invest more and deepen its relationship with UiPath or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Tanabe Pharma revenues, which have grown to $3.27 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Tanabe Pharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| UiPath | Legacy | Uipath Orchestrator | Robotic Process Automation | PaaS | n/a | 2018 | 2019 |
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||